ClassID:

94023

C07D203/08 - CPC Classification

Classification description:

Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom

Sub-classes:
Recent Application in this class:
#1
20250269037
2025-08-28

COMPOUNDS, COMPLEXES, AND METHODS FOR THEIR PREPARATION AND OF THEIR USE

#2
20250230125
2025-07-17

Small Molecule Allosteric Modulators of Serotonin (5-HT) 5-HT2C and 5-HT2A Receptors

#3
20250115551
2025-04-10

SYNTHESIS OF RAS INHIBITORS

#4
20240425447
2024-12-26

BENZOYLGLYCINE DERIVATIVES AND METHODS OF MAKING AND USING SAME

#5
20210206715
2021-07-08

Benzoylglycine derivatives and methods of making and using same

#6
20200247777
2020-08-06

Derivatives of EPA endocannabinoid epoxides as anti-inflammatory, anti-cancerous, anti-angiogenc and antiplatelet aggregation compounds

#7
20200078476
2020-03-12

Aryl ethene derivative and pharmaceutical composition containing same as active ingredient

#8
20190367446
2019-12-05

Benzoylglycine derivatives and methods of making and using same

#9
20190211236
2019-07-11

Post-curable pressure-sensitive adhesive

#10
20190161490
2019-05-30

Aryl ethene derivative and pharmaceutical composition containing same as active ingredient

#11
20180222838
2018-08-09

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#12
20170342030
2017-11-30

Method and catalyst for synthesising aziridine

#13
20170275397
2017-09-28

(Meth)acrylate compound, and copolymer and homopolymer comprising repeating unit derived from same

#14
20170152225
2017-06-01

METHOD AND CATALYST FOR SYNTHESISING AZIRIDINE

#15
20170057939
2017-03-02

Carboxylic acid derivatives and use thereof in the preparation of prodrugs

#16
20170050920
2017-02-23

Water-soluble propofol derivatives and uses thereof

#17
20160340305
2016-11-24

Direct stereospecific synthesis of unprotected aziridines from olefins

#18
20160318863
2016-11-03

Catalyst for synthesizing ethylenimine as well as preparation method and application thereof

#19
20160166885
2016-06-16

Carboxylic branched chain-cutting agent for golf ball-covering ionomer resin, golf ball coating composition, and method for manufacturing golf ball

#20
20160158133
2016-06-09

Primecoat compositions for proteinaceous substrates and methods of priming proteinaceous substrates therewith

#21
20150368197
2015-12-24

COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES OF THE LUNG

#22
20150166478
2015-06-18

Method and catalyst for synthesising aziridine

#23
20150057238
2015-02-26

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#24
20150025241
2015-01-22

Method for preparing dipeptidyl peptidase-IV inhibitor and intermediate

#25
20140296446
2014-10-02

Modifying Polymeric Materials By Amines

#26
20140296294
2014-10-02

Cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases

#27
20130281695
2013-10-24

Intermediates of sitagliptin and preparation process thereof

#28
20130266733
2013-10-10

Primecoat compositions for proteinaceous substrates and methods of priming proteinaceous substrates therewith

#29
20130261099
2013-10-03

Fatty Acid Inhibitors

#30
20130172388
2013-07-04

Cannabinoid receptor 2 (CB2) inverse agonists and therapeutic potential for multiple myeloma and osteoporosis bone diseases

#31
20120016125
2012-01-19

METHOD FOR PREPARING DIPEPTIDYL PEPTIDASE-IV INHIBITOR AND INTERMEDIATE

#32
20110152445
2011-06-23

(Meth)acryloyl-aziridine crosslinking agents and adhesive polymers

#33
20110137047
2011-06-09

Process for enantiomerically pure 8-Aryloctanoic acids as Aliskiren

#34
20110105458
2011-05-05

Fatty acid inhibitors

#35
20100191000
2010-07-29

METHOD FOR SYNTHESIZING AN N-UNSUBSTITUTED OR N-SUBSTITUTED AZIRIDINE

#36
20100137469
2010-06-03

Aziridine-functional photoactive crosslinking compounds

#37
20100056806
2010-03-04

C-H bond amination and olefin aziridination with β-diketiminato copper catalysts

#38
20090227649
2009-09-10

Management of Ophthalmologic Disorders, Including Macular Degeneration

#39
20090022664
2009-01-22

Radiolabelling via fluorination of aziridines

#40
20080269324
2008-10-30

Management of Ophthalmologic Disorders, Including Macular Degeneration

#41
20080262265
2008-10-23

Continuous process for the preparation of alkyleneimines

#42
20060069078
2006-03-30

Management of ophthalmologic disorders, including macular degeneration

#43
20060010609
2006-01-19

Stabilised compositions containing polyfunctional aziridine compounds as hardening constituents

#44
20050143586
2005-06-30

Process for producing optically active amino acid derivatives